Last $35.62 USD
Change Today -0.12 / -0.34%
Volume 219.6K
As of 8:10 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

ensign group inc/the (ENSG) Snapshot

Open
$35.69
Previous Close
$35.74
Day High
$35.95
Day Low
$35.38
52 Week High
08/21/14 - $35.95
52 Week Low
08/22/13 - $20.83
Market Cap
798.3M
Average Volume 10 Days
122.0K
EPS TTM
$1.89
Shares Outstanding
22.4M
EX-Date
06/26/14
P/E TM
18.9x
Dividend
$0.28
Dividend Yield
0.77%
Current Stock Chart for ENSIGN GROUP INC/THE (ENSG)

ensign group inc/the (ENSG) Related Bloomberg News

View More Bloomberg News

ensign group inc/the (ENSG) Related Businessweek News

No Related Businessweek News Found

ensign group inc/the (ENSG) Details

The Ensign Group, Inc., through its subsidiaries, provides skilled nursing and rehabilitative care services in the United States. It offers healthcare services, including skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care services. The company provides its skilled nursing services to Medicaid, private pay, managed care, and Medicare payors. Its skilled nursing facilities offer Medicaid-covered services to individuals consisting of nursing care, room and board, and social services, as well as other services, such as physical, occupational, and speech and rehabilitation therapy services. As of July 17, 2014, the company operated 126 facilities, 10 hospice companies, 10 home health businesses, and 12 urgent care clinics in California, Arizona, Texas, Washington, Utah, Idaho, Colorado, Nevada, Iowa, Nebraska, Oregon and Wisconsin. The Ensign Group, Inc. was founded in 1999 and is based in Mission Viejo, California.

ensign group inc/the (ENSG) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $879.4K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $540.2K
General Counsel and Vice President
Total Annual Compensation: $382.9K
Chief Operating Officer of Ensign Services, I...
Total Annual Compensation: $684.0K
Compensation as of Fiscal Year 2013.

ensign group inc/the (ENSG) Key Developments

The Ensign Group, Inc. Approves Amended and Restated Bylaws

At a meeting of the Board of Directors of The Ensign Group, Inc. held on August 5, 2014, the Board approved and adopted, effective as of August 5, 2014, an amendment to the Amended and Restated Bylaws of the company. The Amendment restates Section 2.07 of the Bylaws in its entirety to provide that director nominees shall be elected by the affirmative vote of the majority of votes cast at an annual meeting of the shareholders in uncontested director elections, with a plurality vote standard retained for director elections where the number of director nominees exceeds the number of board seats.

The Ensign Group, Inc., Board Meeting, Aug 05, 2014

The Ensign Group, Inc., Board Meeting, Aug 05, 2014. Agenda: To approve and adopt effective as of August 5, 2014, an amendment to the amended and restated bylaws of the company.

The Ensign Group, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Year 2014; Provides Earnings Guidance for the Year 2015

The Ensign Group, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2014. For the quarter, the company’s revenue was USD 250,043,000 against USD 220,086,000 for the same period of last year. Income from operations was USD 13,642,000 against USD 23,292,000 for the same period of last year. Income before provision for income taxes was USD 5,056,000 against USD 20,276,000 for the same period of last year. Income from continuing operations attributable to the company was USD 2,007,000 or USD 0.09 per diluted share against USD 12,393,000 or USD 0.55 per diluted share for the same period of last year. Net income attributable to the company was USD 2,007,000 or USD 0.09 per diluted share against USD 12,367,000 or USD 0.55 per diluted share for the same period of last year. On Non-GAAP basis, revenue was USD 246,528,000 against USD 217,960,000 for the same period of last year. Income from operations was USD 22,379,000 against USD 25,316,000 for the same period of last year. Income before provision for income taxes was USD 20,156,000 against USD 22,300,000 for the same period of last year. Income from continuing operations attributable to the company was USD 12,357,000 or USD 0.54 per diluted share against USD 13,678,000 or USD 0.61 per diluted share for the same period of last year. Net income attributable to the company was USD 12,357,000 or USD 0.54 per diluted share against USD 13,652,000 or USD 0.61 per diluted share for the same period of last year. EBITDA was USD 21,920,000 against USD 31,926,000 for the same period of last year. Adjusted EBITDA was USD 29,812,000 against USD 33,404,000 for the same period of last year. EBITDAR was USD 30,203,000 against USD 35,264,000 for the same period of last year. Adjusted EBITDAR was USD 37,570,000 against USD 36,489,000 for the same period of last year. Net cash from operations was USD 37.1 million for the quarter. For the six months, the company’s revenue was USD 489,696,000 against USD 438,287,000 for the same period of last year. Income from operations was USD 37,989,000 against USD 12,538,000 for the same period of last year. Income before provision for income taxes was USD 26,199,000 against USD 6,500,000 for the same period of last year. Income from continuing operations attributable to the company was USD 15,533,000 or USD 0.68 per diluted share against USD 1,994,000 or USD 0.09 per diluted share for the same period of last year. Net income attributable to the company was USD 15,533,000 or USD 0.68 per diluted share against USD 220,000 or USD 0.01 per diluted share for the same period of last year. On Non-GAAP basis, revenue was USD 483,218,000 against USD 435,388,000 for the same period of last year. Income from operations was USD 49,587,000 against USD 51,397,000 for the same period of last year. Income before provision for income taxes was USD 44,222,000 against USD 45,359,000 for the same period of last year. Income from continuing operations attributable to the company was USD 27,116,000 or USD 1.18 per diluted share against USD 28,223,000 or USD 1.27 per diluted share for the same period of last year. Net income attributable to the company was USD 27,116,000 or USD 1.18 per diluted share against USD 26,449,000 or USD 1.19 per diluted share for the same period of last year. Net cash provided by operating activities was USD 37,076,000 against USD 26,607,000 for the same period of last year. EBITDA was USD 55,614,000 against USD 29,268,000 for the same period of last year. Adjusted EBITDA was USD 65,656,000 against USD 67,316,000 for the same period of last year. EBITDAR was USD 67,446,000 against USD 35,920,000 for the same period of last year. Adjusted EBITDAR was USD 76,359,000 against USD 73,460,000 for the same period of last year. The company reaffirmed guidance for projected revenue at USD 1.01 billion to USD 1.025 billion and updated 2014 annual earnings guidance, projecting net income of USD 50.1 million to USD 51.2 million and USD 2.16 to USD 2.21 per diluted share for the year. The updated guidance is based on the impact of the separation of Ensign's healthcare business and certain real estate assets that was completed on June 1, 2014, which resulted in an increase in rent and diluted weighted average common shares to 23.2 million, and a reduction in depreciation and interest expenses. The guidance also assumes, among other things, acquisitions closed to date, anticipated Medicare and Medicaid reimbursement rate increases net of provider taxes, and tax rates of 38.5%. The Management also provided 2015 annual guidance, projecting revenues of USD 1.14 billion to USD 1.16 billion in revenues, with net income of USD 58.1 million to USD 60.2 million and USD 2.44 to USD 2.53 per diluted share for the year. The 2015 guidance is based on diluted weighted average common shares outstanding of 23.8 million and assumes, among other things, acquisitions anticipated to be closed by the end of 2014, anticipated Medicare and Medicaid reimbursement rate increases net of provider taxes, and tax rates of 38.5%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENSG:US $35.62 USD -0.12

ENSG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ENSG.
View Industry Companies
 

Industry Analysis

ENSG

Industry Average

Valuation ENSG Industry Range
No financial data is available for ENSG.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENSIGN GROUP INC/THE, please visit www.ensigngroup.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.